604 related articles for article (PubMed ID: 29370410)
1. Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.
Torres PJ; Siakowska M; Banaszewska B; Pawelczyk L; Duleba AJ; Kelley ST; Thackray VG
J Clin Endocrinol Metab; 2018 Apr; 103(4):1502-1511. PubMed ID: 29370410
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Leber B; Horvath A; Pieber TR; Gorkiewicz G; Stadlbauer V; Obermayer-Pietsch B
PLoS One; 2017; 12(1):e0168390. PubMed ID: 28045919
[TBL] [Abstract][Full Text] [Related]
3. The Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits.
Lüll K; Arffman RK; Sola-Leyva A; Molina NM; Aasmets O; Herzig KH; Plaza-Díaz J; Franks S; Morin-Papunen L; Tapanainen JS; Salumets A; Altmäe S; Piltonen TT; Org E
J Clin Endocrinol Metab; 2021 Mar; 106(3):858-871. PubMed ID: 33205157
[TBL] [Abstract][Full Text] [Related]
4. Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population.
Mammadova G; Ozkul C; Yilmaz Isikhan S; Acikgoz A; Yildiz BO
Eur J Clin Invest; 2021 Apr; 51(4):e13417. PubMed ID: 32991745
[TBL] [Abstract][Full Text] [Related]
5. Exposure to a Healthy Gut Microbiome Protects Against Reproductive and Metabolic Dysregulation in a PCOS Mouse Model.
Torres PJ; Ho BS; Arroyo P; Sau L; Chen A; Kelley ST; Thackray VG
Endocrinology; 2019 May; 160(5):1193-1204. PubMed ID: 30924862
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota and the Polycystic Ovary Syndrome: Influence of Sex, Sex Hormones, and Obesity.
Insenser M; Murri M; Del Campo R; Martínez-García MÁ; Fernández-Durán E; Escobar-Morreale HF
J Clin Endocrinol Metab; 2018 Jul; 103(7):2552-2562. PubMed ID: 29897462
[TBL] [Abstract][Full Text] [Related]
7. Sex, Microbes, and Polycystic Ovary Syndrome.
Thackray VG
Trends Endocrinol Metab; 2019 Jan; 30(1):54-65. PubMed ID: 30503354
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.
Zhou L; Ni Z; Yu J; Cheng W; Cai Z; Yu C
Front Endocrinol (Lausanne); 2020; 11():628. PubMed ID: 33013704
[No Abstract] [Full Text] [Related]
9. Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.
Yang T; Li G; Xu Y; He X; Song B; Cao Y
BMC Microbiol; 2024 May; 24(1):169. PubMed ID: 38760705
[TBL] [Abstract][Full Text] [Related]
10. Characterization on gut microbiome of PCOS rats and its further design by shifts in high-fat diet and dihydrotestosterone induction in PCOS rats.
Zheng Y; Yu J; Liang C; Li S; Wen X; Li Y
Bioprocess Biosyst Eng; 2021 May; 44(5):953-964. PubMed ID: 32157446
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
Liang Z; Di N; Li L; Yang D
J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
[TBL] [Abstract][Full Text] [Related]
12. Blood Bacterial 16S rRNA Gene Alterations in Women With Polycystic Ovary Syndrome.
Wang Q; Wang Q; Zhao L; Bin Y; Wang L; Wang L; Zhang K; Li Q
Front Endocrinol (Lausanne); 2022; 13():814520. PubMed ID: 35282443
[TBL] [Abstract][Full Text] [Related]
13. The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome.
Kelley ST; Skarra DV; Rivera AJ; Thackray VG
PLoS One; 2016; 11(1):e0146509. PubMed ID: 26731268
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
15. Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome.
Lin W; Wen L; Wen J; Xiang G
Front Endocrinol (Lausanne); 2021; 12():747888. PubMed ID: 34858330
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review.
Guo J; Shao J; Yang Y; Niu X; Liao J; Zhao Q; Wang D; Li S; Hu J
Reprod Sci; 2022 Jan; 29(1):69-83. PubMed ID: 33409871
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
[TBL] [Abstract][Full Text] [Related]
18. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome.
Chu W; Han Q; Xu J; Wang J; Sun Y; Li W; Chen ZJ; Du Y
Fertil Steril; 2020 Jun; 113(6):1286-1298.e4. PubMed ID: 32482258
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus.
Codner E; Soto N; Lopez P; Trejo L; Avila A; Eyzaguirre FC; Iniguez G; Cassorla F
J Clin Endocrinol Metab; 2006 Jun; 91(6):2250-6. PubMed ID: 16569737
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
